BTC $78,711.44 -1.41%
ETH $2,479.73 -1.25%
BNB $752.89 +0.62%
XRP $1.39 -1.52%
SOL $103.15 -2.30%
TRX $0.3366 -0.02%
DOGE $0.0898 -0.32%
ADA $0.2182 -1.10%
BCH $259.79 +0.54%
LINK $12.68 -5.05%
HYPE $84.32 -2.67%
AAVE $131.63 -2.99%
SUI $0.8224 +1.83%
XLM $0.1908 -0.46%
ZEC $1,133.79 -6.31%
BTC $78,711.44 -1.41%
ETH $2,479.73 -1.25%
BNB $752.89 +0.62%
XRP $1.39 -1.52%
SOL $103.15 -2.30%
TRX $0.3366 -0.02%
DOGE $0.0898 -0.32%
ADA $0.2182 -1.10%
BCH $259.79 +0.54%
LINK $12.68 -5.05%
HYPE $84.32 -2.67%
AAVE $131.63 -2.99%
SUI $0.8224 +1.83%
XLM $0.1908 -0.46%
ZEC $1,133.79 -6.31%

Quantum BioPharma Q3 Financial Report: Achieved $572,000 in Revenue through Digital Asset Portfolio

2025-11-08 08:53:05

According to GlobeNewswire, Quantum BioPharma (NASDAQ: QNTM) today announced its financial results for the third quarter of 2025, showing a significant improvement in the company's financial condition, with a 275% quarter-over-quarter increase in shareholder equity, a 50% reduction in total liabilities, and an 87% decrease in the debt-to-equity ratio.

The company's digital asset portfolio (primarily consisting of Bitcoin) has realized a gain of $572,000, with the total value of digital assets increasing from $800,000 at the end of 2024 to the current $5.2 million.

app_icon
ChainCatcher Building the Web3 world with innovations.